As of December 2025 Theravance Biopharma has a market cap of โน84.44 Billion. This makes Theravance Biopharma the world's 6060th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 5th, 2025 the market cap of Theravance Biopharma was reported to be: